Ketotifen Unit Dose Stulln

Ketotifen, the active ingredient in Ketotifen Unit Dose Stulln, is an antihistamine (mast cell stabilizer) presented as a unit‑dose eye drop for ocular use. It treats allergic conjunctivitis and ocular itching caused by allergy in patients of all ages.

GNH USA supplies Ketotifen Unit Dose Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketotifen is used to manage allergic conditions of the eye by stabilising mast cells and blocking histamine receptors.

- Allergic conjunctivitis: reduces redness, swelling and itching of the conjunctiva. - Ocular itching due to allergy: provides rapid relief of itch and discomfort. - Seasonal allergic eye disease: helps control symptoms during pollen seasons.

Ketotifen eye drops are generally well tolerated, but some patients may experience local reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Transient blurred vision after instillation. - Mild eye irritation or foreign‑body feeling.

Serious or Rare Side Effects: - Allergic reaction with swelling of the eyelids or face. - Severe eye pain or sudden loss of vision. - Corneal ulceration or keratitis. - Persistent redness unresponsive to treatment. - Vision changes requiring immediate ophthalmic evaluation.

When using Ketotifen eye drops, consider the following safety measures.

- Hypersensitivity: avoid use in patients with known allergy to ketotifen or any excipients. - Glaucoma: use with caution in patients with narrow‑angle glaucoma. - Contact lenses: remove lenses before instillation and wait at least 15 minutes before reinserting. - Symptom monitoring: discontinue and seek medical advice if symptoms worsen or new ocular pain develops. - Systemic antihistamines: be aware of additive antihistaminic effects. - Store at room temperature: keep in the original container, protect from light and moisture.

Ketotifen may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of other topical antihistamines: may increase risk of ocular irritation. - MAO inhibitors combined with systemic antihistamines: can potentiate antihistaminic effects.

Moderate Interactions (Monitor Closely): - Systemic antihistamines (e.g., cetirizine): monitor for additive sedation. - Ocular anesthetics: may enhance local discomfort. - Other mast‑cell stabilisers: assess for overlapping therapeutic effect.